Syenza Resources
Innovation and Access
Adapting PRISMA for Simulation Models in Healthcare
This adapted PRISMA connects evidence synthesis with dynamic modeling. It supports informed decisions through reproducible processes. Ready to learn more? Download the poster today!
From Economics to Access: The State of Biosimilars
Biosimilars delivered $23.6 billion in US savings (2015–2023) and are projected to reach an $88 billion global market by 2030. Learn about cost dynamics, competitive trends, and patient outcomes!
From Innovation to Impact: The Lenacapavir Journey
The FDA approval of Lenacapavir introduces a new chapter in HIV prevention care. Learn more about the innovation and impact of Lenacapavir by downloading our report today!
From Innovation to Outcomes: The Cardiovascular Care Pathway
How is early detection changing cardiovascular disease prevention globally? Technology and equitable access define the future of heart health. Learn more by downloading our report today!
From Innovation to Access: The Gene Therapy Transformation
From NICE approvals for CASGEVY to CMS-negotiated frameworks, federal-state models are paving the way for high-cost therapies. Read more on the advances in gene therapy and download our report today!
From Prevention to Detection: The Cervical Cancer Elimination Journey
Can innovation close the cervical cancer prevention gap? At-home testing approved, achieving 96% accuracy for under-screened populations. Download our report and read about the latest news today!
From Innovation to Access: The GLP-1 Transformation
From market dynamics to patient solutions, the GLP-1 landscape continues to evolve. Scientific innovation meets access solutions in metabolic health care. Read more about the GLP-1 Transformation and download our report today!
Advancing Early Detection: Cancer Screening Progress
Advancements in early detection are reshaping public health strategies. Can new approaches make cancer screening more effective for all? Stay up to date on the latest advancements and download our report today!
Healthcare Perspectives
Syenza's Monthly Picks (March 2026)
March’s Healthcare Perspectives including updates on EMA regulatory improvements and ePI initiatives, brain-computer interface approval for spinal injury treatment in China, vitamin B6 monitoring updates for Parkinson’s therapy and more!
Syenza's Monthly Picks (February 2026)
Topics include diabetes, HIV regimens, and oncology updates. Discover how these developments impact patients and healthcare systems.
Syenza's Monthly Picks (January 2026)
January’s Healthcare Perspectives covers NICE’s endorsement of talazoparib-enzalutamide, FDA updates and more.
Syenza's Monthly Picks (December 2025)
From precision oncology to digital cardiac rehabilitation, healthcare systems balance innovation incentives with equitable access.
